Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy

Name: Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy
License: Public Domain

Federation Francophone de Cancerologie Digestive

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hcc - hepatocellular carcinoma, metastatic cancer, metastatic tumor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143584
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.